INFLECTION POINT ACQUISITION CORP. IV: Shareholders Approve Merger with Merlin Labs, Paving the Way for Autonomous Flight Innovation

Inflection Point Acquisition Corp. IV (IPAQ) has reached a pivotal milestone. This summary breaks down the recent developments in plain language, explaining what this means for investors and the future of the combined company.

1. Event Description

On March 12, 2026, IPAQ shareholders overwhelmingly approved the proposed merger with Merlin Labs, Inc. (Merlin). This approval is more than just an intent; it represents the official mandate from IPAQ's owners to proceed with creating a new, publicly traded entity focused on cutting-edge autonomous flight technology.

Shareholders voted on several critical proposals, all of which passed with strong support, typically receiving over 90% of votes cast in favor:

• Business Combination Agreement: Shareholders approved the core merger agreement, under which Merlin Labs will become a wholly-owned subsidiary of the new public company.
• Domestication: They approved the change of IPAQ's legal domicile from the Cayman Islands to Delaware. This is a standard procedure that streamlines legal and operational aspects for the combined U.S.-based company.
• New Governing Documents: Shareholders approved the new Certificate of Incorporation and Bylaws for the combined company, which will officially be named Merlin, Inc. These documents establish the governance structure and operational framework.
• Share Issuances: Approval was granted for issuing shares to Merlin's current owners, based on an agreed exchange ratio, and for other related financing agreements. This includes a $50 million PIPE (Private Investment in Public Equity) investment, which will provide additional capital.
• Leadership & Incentive Plans: Shareholders elected seven directors to the new board of Merlin, Inc., comprising experienced industry leaders and technology visionaries. They also approved new stock incentive and employee stock purchase plans designed to attract and retain top talent for the future Merlin, Inc. team.

IPAQ formed as a Special Purpose Acquisition Company (SPAC) with the explicit goal of identifying and merging with a promising private company to bring it to the public market. IPAQ identified Merlin Labs as that partner, signing the initial merger agreement on August 13, 2025.

Merlin Labs leads the field in autonomous flight technology. The company develops advanced software and hardware solutions that enable aircraft to operate with significantly reduced human intervention, aiming for fully autonomous capabilities. Merlin's strategy focuses on disrupting the aviation industry by enhancing safety, efficiency, and accessibility through its proprietary AI-driven systems. IPAQ's shareholders clearly recognized Merlin's strong potential in this rapidly evolving market, voting overwhelmingly to approve the merger as a strategic investment in the future of aviation.

2. Event Date/Timeline

The special meeting of shareholders occurred on March 12, 2026. IPAQ officially reported the results via an 8-K filing after market close on the same day, ensuring all investors received the news simultaneously.

With shareholder approval secured, IPAQ and Merlin Labs will now diligently work to finalize all remaining legal, regulatory, and administrative steps. This includes satisfying all closing conditions outlined in the merger agreement. The merger is expected to officially close in late Q1 or early Q2 2026. Upon closing, Inflection Point Acquisition Corp. IV will change its name to Merlin, Inc. and anticipates beginning trading on the Nasdaq under the new ticker symbol "MRLN" (or a similar variant).

3. Impact Assessment

This shareholder approval marks a monumental step. IPAQ transitions from a "blank check" company searching for a deal to a company firmly on the path to becoming a real, operating business through its merger with Merlin Labs. This process, known as "de-SPACing," represents the ultimate goal for any SPAC, signifying the transition from a shell company to a substantive entity with a defined business model and growth strategy.

• Investors: If you own IPAQ shares, your investment's future has become significantly clearer and more defined. You are now invested in a company officially approved to merge with Merlin Labs. However, understanding the impact of shareholder redemptions is crucial. While the merger is approved, the final cash available to Merlin, Inc. will depend on how many IPAQ shareholders chose to redeem their shares for cash before the vote. High redemptions could reduce the capital available for Merlin's growth and potentially increase the ownership percentage of PIPE investors and original Merlin shareholders.
• IPAQ Management & Team: They have successfully achieved their primary goal of identifying a target and securing shareholder approval. Their focus now shifts to finalizing the deal and ensuring a smooth integration with Merlin Labs.
• Merlin Labs (the target company): Employees, current owners, and customers of Merlin Labs are directly affected as the company prepares to become publicly traded. This transition provides access to significant new capital for research, development, and scaling operations, along with increased market visibility and credibility.
• Future "Merlin, Inc.": All involved parties will soon be part of a new, combined entity with a new name and structure, poised to innovate in the autonomous flight space.

4. Financial Impact

The approved business combination values Merlin Labs at an estimated $1.5 billion enterprise value. A $50 million Private Investment in Public Equity (PIPE) investment forms part of the financing structure, providing additional capital to the combined entity.

The definitive financial impact on the combined company's balance sheet and available cash will largely depend on the level of shareholder redemptions by IPAQ public shareholders before the business combination closes. High redemptions could reduce the cash proceeds available to Merlin, Inc. for its operations and growth initiatives. Investors should also consider the potential for dilution from the issuance of new shares to Merlin's existing owners and the PIPE investors. Pro forma financial statements detailing the expected financial position of the combined company post-merger are available in the definitive proxy statement (Form S-4) filed with the SEC.

5. Key Takeaways for Investors

Here are the essential points for investors to consider:

• Expect Volatility: This type of news often causes stock prices to fluctuate as the market processes the implications of the approved merger and anticipates its closing. Be prepared for significant price swings in the short term.
• Deep Dive into Merlin Labs: Now, more than ever, thoroughly research Merlin Labs. Understand its core technology, competitive advantages, financial projections, revenue streams, and path to profitability. The future of your investment is now directly tied to their business performance and execution.
• Understand Financials & Redemptions: Review the definitive proxy statement (Form S-4) filed with the SEC. Pay close attention to the pro forma financials, the total cash expected to be available to Merlin, Inc. after redemptions, and the potential dilution from new share issuances and the PIPE investment. The level of redemptions by IPAQ shareholders directly impacts the cash Merlin will have for growth.
• Assess the Risks: Investing in a newly public company, especially in a high-growth tech sector like autonomous flight, carries inherent risks. These include technological development risks, regulatory hurdles, intense competition, market adoption challenges, and the ability to scale operations. Familiarize yourself with the "Risk Factors" section in the S-4 filing.
• Stay Informed: Monitor official closing announcements and the exact date when the new ticker symbol will take effect. Continue to check official company filings (such as those on the SEC's EDGAR website – search for IPAQ, and soon MRLN) and reputable financial news sources for updates on the merger's completion and the new company's operations.
• Long-Term vs. Short-Term: Recognize that you are transitioning from owning a SPAC to owning a piece of an operating business. This significantly alters the investment profile, often shifting from speculative trading to a focus on long-term business fundamentals.
• Make Informed Decisions: Base your investment decisions on solid research about Merlin Labs, its business model, and the combined entity's prospects, rather than on short-term market reactions or the fear of missing out. Consider consulting a financial advisor.